Sheila V. Clark

Array ( [id] => 5502814 [patent_doc_number] => 20090163502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists' [patent_app_type] => utility [patent_app_number] => 12/317026 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38805 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163502.pdf [firstpage_image] =>[orig_patent_app_number] => 12317026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055832 [patent_doc_number] => 20110112192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'VERFAHREN ZUR GERUCHSEXTINKTION' [patent_app_type] => utility [patent_app_number] => 12/808011 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1712 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112192.pdf [firstpage_image] =>[orig_patent_app_number] => 12808011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550752 [patent_doc_number] => 08063085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Substituted hydantoins' [patent_app_type] => utility [patent_app_number] => 12/331538 [patent_app_country] => US [patent_app_date] => 2008-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30387 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063085.pdf [firstpage_image] =>[orig_patent_app_number] => 12331538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445909 [patent_doc_number] => 20100144737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'METHODS FOR INHIBITING T HELPER CELL DIFFERENTIATION' [patent_app_type] => utility [patent_app_number] => 12/316028 [patent_app_country] => US [patent_app_date] => 2008-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25340 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144737.pdf [firstpage_image] =>[orig_patent_app_number] => 12316028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480738 [patent_doc_number] => 20090203695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Compounds IV' [patent_app_type] => utility [patent_app_number] => 12/315830 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8964 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203695.pdf [firstpage_image] =>[orig_patent_app_number] => 12315830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343317 [patent_doc_number] => 20090181967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'New compounds I' [patent_app_type] => utility [patent_app_number] => 12/315698 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22489 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181967.pdf [firstpage_image] =>[orig_patent_app_number] => 12315698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380488 [patent_doc_number] => 20090192327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS' [patent_app_type] => utility [patent_app_number] => 12/327349 [patent_app_country] => US [patent_app_date] => 2008-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7537 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192327.pdf [firstpage_image] =>[orig_patent_app_number] => 12327349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421848 [patent_doc_number] => 08278336 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 12/743013 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26420 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598431 [patent_doc_number] => 20100048706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Ethoxylated and/or Hydrogenated Oil Adduct' [patent_app_type] => utility [patent_app_number] => 12/528889 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7923 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048706.pdf [firstpage_image] =>[orig_patent_app_number] => 12528889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533119 [patent_doc_number] => 20090232907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Compositions and methods for treatment of esophageal cancer' [patent_app_type] => utility [patent_app_number] => 12/313179 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 27538 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232907.pdf [firstpage_image] =>[orig_patent_app_number] => 12313179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539823 [patent_doc_number] => 20090221628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Compositions and methods for treatment of prostate and breast cancer' [patent_app_type] => utility [patent_app_number] => 12/313186 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 27851 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221628.pdf [firstpage_image] =>[orig_patent_app_number] => 12313186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355571 [patent_doc_number] => 20090186915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Compositions and methods for treatment of glioblastoma, gliosarcoma, NSCLC, and head and neck cancer' [patent_app_type] => utility [patent_app_number] => 12/313187 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 28377 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186915.pdf [firstpage_image] =>[orig_patent_app_number] => 12313187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276141 [patent_doc_number] => 20100256181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/742159 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45113 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256181.pdf [firstpage_image] =>[orig_patent_app_number] => 12742159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265573 [patent_doc_number] => 20090118258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'COMBINATION THERAPY COMPRISING ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND VASOPRESSIN RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/265098 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9179 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118258.pdf [firstpage_image] =>[orig_patent_app_number] => 12265098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267709 [patent_doc_number] => 20100298402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'STILBENE DERIVATIVES AS PSTAT3/IL-6 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/734484 [patent_app_country] => US [patent_app_date] => 2008-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16914 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298402.pdf [firstpage_image] =>[orig_patent_app_number] => 12734484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533429 [patent_doc_number] => 08309583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Desferrioxamine conjugates, derivatives and analogues' [patent_app_type] => utility [patent_app_number] => 12/740957 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8739 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5507958 [patent_doc_number] => 20090081165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'BICYCLIC HETEROARYL DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/262093 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86673 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081165.pdf [firstpage_image] =>[orig_patent_app_number] => 12262093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452327 [patent_doc_number] => 20090068364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Method of surface treatment using imidazole compound' [patent_app_type] => utility [patent_app_number] => 12/290328 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2135 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068364.pdf [firstpage_image] =>[orig_patent_app_number] => 12290328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576062 [patent_doc_number] => 20090143424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'TETRAKIS-QUATERNARY AMMONIUM SALTS AND METHODS FOR MODULATING NEURONAL NICOTINIC ACTEYLCHOLINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/260502 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15606 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143424.pdf [firstpage_image] =>[orig_patent_app_number] => 12260502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690027 [patent_doc_number] => 08389555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Medicaments' [patent_app_type] => utility [patent_app_number] => 12/740147 [patent_app_country] => US [patent_app_date] => 2008-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 22 [patent_no_of_words] => 35343 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740147 [rel_patent_id] =>[rel_patent_doc_number] =>)